Wugen

Redirect

St. Louis, United States · Founded 2018 · $287.0M raised

Founded
2018
Website
wugen.com
Total Funding
$287.0M
Last Round
$115.0M Series CAug 2025
Rounds
2

About

Wugen, Inc., headquartered in St. Louis, Missouri, is a clinical-stage biotechnology company focused on developing next-generation, allogeneic CAR-T cell therapies for cancer. Wugen's proprietary gene-editing platform is designed to overcome key limitations of first-generation cell therapies, enabling scalable, off-the-shelf treatments with biologics-like cost of goods margins. Wugen is now Allotera, entering a new era of allogeneic T-cell therapies.

Summary

Wugen is a Biotech company based in St. Louis, United States, founded in 2018. It has raised $287.0M in total across 2 rounds, most recently a $115.0M Series C round in Aug 2025. Investors include Fidelity Management, Abingworth Bioventures and Tybourne Capital Management.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CAug 2025
$115.0M

Sign up to see all 2 rounds

Series B through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Wugen on Indexed.vc
<a href="https://indexed.vc/companies/wugen"><img src="https://indexed.vc/api/badge/company/wugen" alt="Wugen on Indexed.vc" width="260" height="76" /></a>